Pharsight

Welchol patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US7229613 DAIICHI SANKYO INC Method for lowering serum glucose
Apr, 2022

(1 year, 5 months ago)

Welchol is owned by Daiichi Sankyo Inc.

Welchol contains Colesevelam Hydrochloride.

Welchol has a total of 1 drug patent out of which 1 drug patent has expired.

Expired drug patents of Welchol are:

  • US7229613

Welchol was authorised for market use on 03 April, 2019.

Welchol is available in bar, chewable;oral dosage forms.

Welchol can be used as a method for reducing serum glucose levels in adults with type 2 diabetes mellitus.

The generics of Welchol are possible to be released after 17 April, 2022.

Drugs and Companies using COLESEVELAM HYDROCHLORIDE ingredient

Market Authorisation Date: 03 April, 2019

Treatment: A method for reducing serum glucose levels in adults with type 2 diabetes mellitus

Dosage: BAR, CHEWABLE;ORAL

How can I launch a generic of WELCHOL before it's drug patent expiration?
More Information on Dosage

WELCHOL family patents

Family Patents
Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US7229613 DAIICHI SANKYO Method for lowering serum glucose
Apr, 2022

(1 year, 5 months ago)

US7229613

(Pediatric)

DAIICHI SANKYO Method for lowering serum glucose
Oct, 2022

(11 months ago)

Welchol is owned by Daiichi Sankyo.

Welchol contains Colesevelam Hydrochloride.

Welchol has a total of 2 drug patents out of which 2 drug patents have expired.

Expired drug patents of Welchol are:

  • US7229613
  • US7229613*PED

Welchol was authorised for market use on 02 October, 2009.

Welchol is available in for suspension;oral dosage forms.

Welchol can be used as treatment of type 2 diabetes mellitus.

The generics of Welchol are possible to be released after 20 October, 2024.

Drug Exclusivity Drug Exclusivity Expiration
M (M) Oct 20, 2024

Drugs and Companies using COLESEVELAM HYDROCHLORIDE ingredient

Market Authorisation Date: 02 October, 2009

Treatment: Treatment of type 2 diabetes mellitus

Dosage: FOR SUSPENSION;ORAL

How can I launch a generic of WELCHOL before it's drug patent expiration?
More Information on Dosage

WELCHOL family patents

Family Patents

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic